BioSpace News Archive

Invacare Corporation a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for March 2022.

Amgen will virtually present at the 42nd Annual Cowen Healthcare Conference at 11:10 a.m. ET on Tuesday, March 8, 2022.

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the fourth quarter and full year ended December 31, 2021.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced the pricing of an underwritten public offering of $400 million aggregate principal amount of its 3.600% Senior Notes due 2032.

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that senior management will be participating in multiple upcoming institutional investor conferences.

MediWound Ltd., a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration, announced that it intends to offer its ordinary shares for sale in an underwritten public offering.

Tricida, Inc. (Nasdaq: TCDA), announced today an update on the anticipated date for top-line data from the VALOR-CKD trial based on the ongoing events in Ukraine.

Paul J. Diaz, president and CEO of Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will be participating in a fireside chat at the 42nd Annual Cowen Health Care Conference on March 8, 2022 at 9:50 a.m. ET.

AIkido Pharma Inc., announced the closing of its previously announced registered direct offering with certain institutional investors of 11,000 shares of Series O redeemable convertible preferred stock and 11,000 shares of Series P redeemable convertible preferred stock.